Purchase Order 75D30120P09507
Award Date 9/30/20
Potential Completion Date 9/30/20
Potential Value $32K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $31,000.00 firm fixed price purchase order contract to Bioinforx, Inc., a small disadvantaged business, to provide the LABLINK GSL ORDER. This is a one-year contract with a period of performance ending on March 31, 2022. Bioinforx has received several prior federal contracts from the U.S. Department of Health and Human Services (HHS), including the CDC and National Institutes of Health (NIH), to provide scientific data...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Biolytic Lab Performance Inc., a veteran-owned for-profit organization. The contract, valued at $84,950.00, is for the provision of an OLIGO INST (oligonucleotide instrument), with a performance period ending on July 20, 2021. The contract has no set-aside designation. Biolytic Lab Performance Inc. is a provider of DNA synthesis solutions and laboratory equipment, having secured...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a firm fixed-price purchase order contract to Biolytic Lab Performance Inc., a veteran-owned for-profit organization, for the procurement of a DR. OLIGO Synthesizer. The contract, valued at $84,950.00, has an ultimate completion date of April 30, 2020. Biolytic Lab Performance Inc. is a federal contractor that specializes in DNA synthesis solutions and laboratory equipment, and has secured multiple awards from various civilian and...
- This is a $236,603.20 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC), which is part of the Department of Health and Human Services, to Biosearch Technologies, Inc. The award is for the provision of RUO (Research Use Only) oligonucleotides. Biosearch Technologies is a manufacturer of oligonucleotide-based tools, including fluorophores and dark quenchers, and has previously provided laboratory supplies such as primer probes, assay kits, PCR kits,...
- This is a $16,438.00 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Integrated DNA Technologies, Inc. (IDT) for the delivery of custom laboratory oligonucleotides. The contract has no set-aside designation. IDT is a leading manufacturer and supplier of specialized nucleic acid products and services to federal agencies, supporting initiatives such as biomedical research, pandemic response, and public health programs. This award is part of...
- This is a firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Eurofins Genomics LLC, a for-profit manufacturer of goods, to produce oligonucleotides for the CDC's Rapid Production of Oligonucleotides for Circulating Vaccine-Derived Poliovirus (OLIGO CVV RAPID PRODUCTION) program. The contract has a ceiling value of $171,193.00 and a period of performance ending on September 25, 2025. The contract does not have a set-aside designation. Eurofins...
- This firm fixed-price purchase order was awarded to Biolytic Lab Performance Inc., a veteran-owned for-profit organization, by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia. The $54,000 contract is for the maintenance of a medium throughput DNA synthesizer and 42 related reagents. The award was not set aside for any specific business category. Biolytic Lab Performance Inc. specializes in providing scientific instrumentation, particularly oligonucleotide synthesizers...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bio-Synthesis, Inc. (doing business as Dnaexam) for the custom synthesis of oligonucleotides. The contract has a ceiling value of $29,580.00 and an ultimate completion date of February 28, 2010. The agency indicates a high demand and usage level for these oligonucleotides, particularly for a recombinant vaccine project against...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price delivery order contract to Biosearch Technologies, Inc. LGC Biosearch Technologies Division. The $787,500.00 contract, which has no set-aside designation, is for the provision of oligonucleotide-based laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides. These products support the CDC's disease surveillance, diagnostic testing, public health research,...
- This is a $125,000.04 firm-fixed price purchase order awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Base Pair Biotechnologies Inc., a for-profit company that provides custom aptamer development services and products. The contract is for aptamer development services, and does not have a set-aside designation. Through prior contracts and grants, Base Pair Biotechnologies has provided research and development services related to...
This is a $32,000.00 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Bioinforx, Inc., a small disadvantaged business. The contract is for the bulk procurement of oligos, with a period of performance ending on September 30, 2020. Bioinforx, Inc. is a for-profit organization that specializes in developing scientific data management systems and laboratory information technologies, particularly for government health agencies like the CDC and the National Institute of Allergy and Infectious Diseases (NIAID). The contract does not utilize any set-aside designation.
Generated 8/24/25, 12:53 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | ($23k) | 8/18/25 | |
| Not listed | Not listed | $32.0k | 8/20/20 |